Rockefeller Capital Management’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
DGM
Rockefeller Capital Management's GMAB Position: Q3 2026 in Review
Rockefeller Capital Management increased its Genmab (GMAB) stake by 7.9% in Q3 2026, buying an estimated $42K and bringing the position to 18,213 shares worth $650K. The position accounts for ﹤0.01% of the portfolio, ranked #1981.
Rockefeller Capital Management first reported a position in GMAB in Q3 2019 and has held it in 28 quarters since. The position peaked at $770K in Q4 2022. 328 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.
- Rockefeller Capital Management held 18,213 shares of Genmab worth $650K as of Q3 2026.
- Rockefeller Capital Management bought 1,328 Genmab shares in Q3 2026, an estimated $42K.
- Genmab made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #1981 holding.
- Rockefeller Capital Management first reported a position in Genmab in Q3 2019 and has held it in 28 quarters since.
- Rockefeller Capital Management's Genmab position peaked at $770K in Q4 2022.
- 328 funds tracked by Wall St. Rank held Genmab as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.